These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11761508)

  • 1. Caudate hemorrhage as a possible complication of midodrine-induced supine hypertension.
    Sandroni P; Benarroch EE; Wijdicks EF
    Mayo Clin Proc; 2001 Dec; 76(12):1275. PubMed ID: 11761508
    [No Abstract]   [Full Text] [Related]  

  • 2. Supine hypertension during general anesthesia in a patient taking midodrine.
    Chaimberg KH; Travis KW
    Anesth Analg; 2002 Nov; 95(5):1196-7, table of contents. PubMed ID: 12401592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ; Han Y; Tang J; Portillo I; Hauser RA; Dashtipour K
    Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.
    Smith W; Wan H; Much D; Robinson AG; Martin P
    Clin Auton Res; 2016 Aug; 26(4):269-77. PubMed ID: 27372462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
    Cannom DS
    J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1732-1734. PubMed ID: 31599484
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.
    Grijalva CG; Biaggioni I; Griffin MR; Shibao CA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged supine hypertension due to midodrine use in an orthostatic hypotensive child.
    Olgar S; Omeroglu RE
    Pediatr Cardiol; 2007; 28(4):309-10. PubMed ID: 17530320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
    Goodman BP; Claassen D; Mehdirad A
    Clin Auton Res; 2017 Jul; 27(Suppl 1):17-19. PubMed ID: 28631223
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe transient hypertension after greater palatine foramen block in a patient taking midodrine.
    Rizzi MD; Weil RJ; Lorenz RR
    Am J Otolaryngol; 2010; 31(1):67-9. PubMed ID: 19944906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.
    Okamoto LE; Diedrich A; Baudenbacher FJ; Harder R; Whitfield JS; Iqbal F; Gamboa A; Shibao CA; Black BK; Raj SR; Robertson D; Biaggioni I
    Hypertension; 2016 Aug; 68(2):418-26. PubMed ID: 27271310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dystonia induced by the combination of midodrine and perphenazine.
    Castrioto A; Tambasco N; Rossi A; Calabresi P
    J Neurol; 2008 May; 255(5):767-8. PubMed ID: 18344053
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to research letter titled "Severe transient hypertension after greater palatine foramen block in a patient taking midodrine".
    Casserly P; O'Leary G; Moore A
    Am J Otolaryngol; 2011; 32(6):634-5; author reply 635-6. PubMed ID: 21306789
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension.
    Byun JI; Moon J; Kim DY; Shin H; Sunwoo JS; Lim JA; Kim TJ; Lee WJ; Lee HS; Jun JS; Park KI; Lee ST; Jung KH; Jung KY; Lee SK; Chu K
    Neurology; 2017 Sep; 89(10):1078-1086. PubMed ID: 28794253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midodrine for severe orthostatic hypotension.
    Drug Ther Bull; 2016 May; 54(5):54-6. PubMed ID: 27173783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials.
    Parsaik AK; Singh B; Altayar O; Mascarenhas SS; Singh SK; Erwin PJ; Murad MH
    J Gen Intern Med; 2013 Nov; 28(11):1496-503. PubMed ID: 23775146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridostigmine treatment trial in neurogenic orthostatic hypotension.
    Singer W; Sandroni P; Opfer-Gehrking TL; Suarez GA; Klein CM; Hines S; O'Brien PC; Slezak J; Low PA
    Arch Neurol; 2006 Apr; 63(4):513-8. PubMed ID: 16476804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia.
    Wecht JM; Rosado-Rivera D; Handrakis JP; Radulovic M; Bauman WA
    Arch Phys Med Rehabil; 2010 Sep; 91(9):1429-35. PubMed ID: 20801263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine-induced acute generalized exanthematous pustulosis.
    Sadeghpour M; Bunick CG; Robinson DM; Galan A; Tigelaar RE; Imaeda S
    Cutis; 2014 May; 93(5):E17-20. PubMed ID: 24897147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
    Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
    Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.